Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Scleroderma, also known as systemic sclerosis, is a rare and chronic autoimmune disease characterized by the hardening and tightening of the skin and connective tissues. It can affect various organs, including the skin, lungs, heart, kidneys, and gastrointestinal tract. While there is no cure for scleroderma, treatments are available to manage its symptoms and slow its progression. One such treatment option that has shown promise in recent years is stem cell transplantation.

We will delve into the success rates of stem cell transplants for scleroderma, exploring the underlying mechanisms, current practices, challenges, and future perspectives. By understanding the intricacies of this treatment, patients and healthcare providers can make more informed decisions regarding its potential benefits and risks.

Understanding Scleroderma

Scleroderma is a complex autoimmune disease that can vary significantly from one person to another in terms of severity and the organs affected. The primary features of scleroderma include:

  • Fibrosis: The excessive production of collagen, which leads to scarring and hardening of tissues.
  • Vascular Issues: Damage to blood vessels, which can result in poor circulation and other complications.
  • Autoimmune Response: The immune system mistakenly attacks the body’s own tissues, causing inflammation and damage.

There are two main types of scleroderma:

  1. Localized Scleroderma: Limited to the skin and nearby tissues, without affecting internal organs.
  2. Systemic Scleroderma: Also known as systemic sclerosis, this form affects multiple organs and systems in the body and is associated with a higher risk of complications.

Role of Stem Cell Transplants in Scleroderma Treatment

Stem cell transplants, also known as hematopoietic stem cell transplants (HSCT), involve harvesting stem cells from the patient’s bone marrow or peripheral blood, treating them, and then reinfusing them back into the patient. This process aims to reset the immune system, potentially halting the progression of scleroderma.

The primary goal of HSCT for scleroderma is to achieve:

  • Immune Reboot: The transplant can help reset the immune system, potentially reducing autoimmunity and halting disease progression.
  • Improved Quality of Life: Successful transplants may lead to symptom relief and an improved quality of life for patients.

Stem Cell Transplantation Process

The process of stem cell transplantation for scleroderma typically involves the following steps:

Mobilization and Harvesting

First, stem cells are mobilized from the bone marrow to the peripheral blood using a combination of medications such as growth factors and chemotherapy. Once the stem cells are in the peripheral blood, they are collected through a procedure called apheresis.

Conditioning Regimen

Before the stem cells can be reinfused, the patient undergoes a conditioning regimen that typically involves high-dose chemotherapy or a combination of chemotherapy and immunosuppressive drugs. This regimen aims to eliminate the existing immune cells and create space for the new stem cells.

Stem Cell Transplantation

Once the conditioning regimen is complete, the harvested stem cells are reinfused into the patient’s bloodstream. The transplanted stem cells migrate to the bone marrow, where they begin to repopulate the immune system.

Recovery and Monitoring

Following the transplant, patients typically experience a recovery period during which they are closely monitored for complications such as infections, graft-versus-host disease (GVHD), and other adverse effects. Long-term follow-up is essential to assess the transplant’s efficacy and detect any recurrence of scleroderma.

Assessing Success Rates of Stem Cell Transplants for Scleroderma

Determining the success rates of stem cell transplants for scleroderma involves evaluating several factors, including short-term and long-term outcomes, patient survival, and quality of life improvements. The following metrics are commonly used to assess the success of HSCT in scleroderma patients:

Disease Progression and Stabilization

One of the key indicators of success is the ability to halt or slow the progression of scleroderma. Successful transplants often result in disease stabilization, preventing further organ damage and reducing the severity of symptoms.

Symptom Relief

Many patients experience relief from symptoms such as skin hardening, joint pain, and fatigue after undergoing HSCT. Improved lung function and other organ-specific measures are also monitored to assess treatment efficacy.

Survival Rates

Survival rates following stem cell transplantation vary depending on the individual patient and the severity of their condition. Studies have shown promising survival rates for scleroderma patients who undergo HSCT, particularly those with less severe disease at the time of transplantation.

Quality of Life

Improved quality of life is another important metric for evaluating the success of stem cell transplants for scleroderma. Patients often report better physical functioning and overall well-being following transplantation.

Long-Term Outcomes

Long-term outcomes, including the sustainability of treatment benefits and potential complications, are essential for determining the overall success of HSCT. Monitoring patients for several years post-transplant provides insights into the long-term efficacy of the procedure.

Clinical Trials and Research Findings

Numerous clinical trials have been conducted to evaluate the efficacy and safety of stem cell transplants for scleroderma. Some notable trials and their findings include:

  • The Autologous Stem Cell Transplantation International Scleroderma (ASTIS) Trial: This trial compared HSCT with intravenous cyclophosphamide in scleroderma patients. The results showed that HSCT led to significant improvements in skin thickening and lung function compared to cyclophosphamide.
  • The Scleroderma: Cyclophosphamide or Transplantation (SCOT) Trial: This trial compared HSCT with cyclophosphamide in patients with diffuse cutaneous scleroderma. The findings indicated that HSCT was associated with better long-term outcomes, including higher event-free survival rates.

These trials and others provide valuable evidence supporting the use of stem cell transplants for scleroderma, particularly in patients with severe disease who have not responded well to other treatments.

Challenges and Risks

While stem cell transplants offer potential benefits for scleroderma patients, there are also significant challenges and risks associated with the procedure:

Infection and Complications

Patients undergoing HSCT are at increased risk of infections due to the immunosuppressive nature of the conditioning regimen. Careful monitoring and preventive measures are necessary to minimize the risk of complications.

Graft-versus-Host Disease (GVHD)

GVHD is a potential complication of stem cell transplantation, particularly when the transplanted cells recognize the patient’s tissues as foreign and attack them. This can lead to serious health issues and requires careful management.

Relapse and Disease Recurrence

While HSCT can effectively reset the immune system and halt disease progression, there is still a risk of relapse or recurrence of scleroderma in some patients.

High Cost and Limited Availability

Stem cell transplants can be expensive, and access to the procedure may be limited in some regions. This poses a barrier for patients who could benefit from the treatment.

Individual Variability

The success of HSCT for scleroderma can vary significantly from one patient to another due to differences in disease severity, overall health, and other factors. This variability makes it challenging to predict outcomes for individual patients.

Emerging Therapies

While stem cell transplants have shown promise in the treatment of scleroderma, ongoing research aims to improve the procedure’s safety and efficacy further. Future directions and emerging therapies in the field include:

Optimizing Conditioning Regimens

Researchers are exploring alternative conditioning regimens that may offer better outcomes with fewer side effects. Lower-intensity regimens and targeted therapies are being investigated.

Mesenchymal Stem Cells (MSCs)

Mesenchymal stem cells (MSCs) are being studied as an alternative to hematopoietic stem cells for transplantation. MSCs may offer anti-inflammatory and immunomodulatory effects that could benefit scleroderma patients.

Personalized Medicine Approaches

Personalized medicine approaches, such as identifying specific genetic markers and tailoring treatments to individual patients, may improve the success rates of stem cell transplants for scleroderma.

Combination Therapies

Combining HSCT with other therapies, such as targeted immunosuppressive drugs or biologics, may enhance the procedure’s effectiveness and reduce the risk of complications.

Improve Quality of Life

Stem cell transplants have emerged as a promising treatment option for scleroderma patients, offering the potential to halt disease progression and improve quality of life. While the success rates vary depending on individual patient factors, clinical trials have demonstrated the efficacy of HSCT in improving outcomes for scleroderma patients.

However, challenges such as infections, GVHD, and relapse remain significant concerns that need to be addressed. Ongoing research aims to optimize the procedure and explore new therapeutic avenues, including personalized medicine and combination therapies.

Patients considering stem cell transplants for scleroderma should consult with experienced healthcare providers to evaluate the potential benefits and risks of the procedure. Through continued research and innovation, stem cell transplants may become an increasingly viable option for scleroderma patients seeking effective treatment.

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Cervical spinal stenosis is a condition characterized by the narrowing of the spinal canal in the neck region, which can compress the spinal cord and nerve roots, leading to pain, numbness, and other neurological symptoms. Traditional treatment options, such as physical therapy, medication, and surgery, aim to alleviate symptoms but often fail to provide a lasting solution. Recently, stem cell therapy has emerged as a promising alternative approach to treat cervical spinal stenosis. We will delve into the potential of stem cell therapy in treating this condition, exploring how it works, its benefits, challenges, and future prospects.

Understanding Cervical Spinal Stenosis

Cervical spinal stenosis is a condition affecting the cervical region (neck) of the spinal column. It involves the narrowing of the spinal canal, which houses the spinal cord and nerves, due to various factors:

Causes of Cervical Spinal Stenosis

  1. Degenerative Changes: As individuals age, the intervertebral discs can lose water content, becoming thinner and less flexible. This can cause the discs to bulge or herniate, potentially narrowing the spinal canal.
  2. Osteoarthritis: The wear and tear on the spinal joints can lead to the formation of bone spurs (osteophytes), which can impinge on the spinal cord and nerves.
  3. Thickening of Ligaments: Over time, the ligaments supporting the spine may thicken and calcify, encroaching on the spinal canal.
  4. Congenital Factors: Some individuals may have a naturally narrow spinal canal, which can increase the risk of developing stenosis.
  5. Injuries: Trauma or injuries to the neck can lead to spinal stenosis.

Symptoms of Cervical Spinal Stenosis

The symptoms of cervical spinal stenosis can vary depending on the severity and location of the compression:

  • Neck pain and stiffness
  • Numbness or tingling in the arms and hands
  • Weakness in the arms and legs
  • Coordination problems and difficulty with fine motor skills
  • Bowel or bladder dysfunction in severe cases

Traditional Treatment Options for Cervical Spinal Stenosis

Traditional treatments aim to manage symptoms and prevent further progression of the condition:

Non-Surgical Interventions

  • Physical Therapy: Exercises to improve posture, strengthen neck muscles, and alleviate pressure on the spinal cord and nerves.
  • Medication: Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain relief, along with muscle relaxants and corticosteroid injections to reduce inflammation.
  • Assistive Devices: Braces or collars may be used to provide support and reduce strain on the neck.

Surgical Interventions

  • Decompression Surgery: Procedures such as laminectomy, foraminotomy, or discectomy involve removing bone spurs, disc material, or ligaments to create more space in the spinal canal.
  • Spinal Fusion: In some cases, spinal fusion may be performed to stabilize the cervical spine.

While traditional treatments can provide relief, they often come with limitations such as incomplete recovery, recurrence of symptoms, or potential complications from surgery. This has led to interest in alternative therapies, including stem cell therapy.

Overview of Stem Cell Therapy

Stem cell therapy is an innovative medical approach that utilizes stem cells to repair or regenerate damaged tissues and organs. Stem cells have unique properties that make them promising for treating various conditions, including cervical spinal stenosis:

Types of Stem Cells

  1. Embryonic Stem Cells: Derived from early-stage embryos, these cells have the potential to differentiate into any cell type in the body. However, their use is controversial and subject to ethical considerations.
  2. Adult Stem Cells: Found in various tissues such as bone marrow, adipose tissue, and peripheral blood, adult stem cells have a more limited differentiation potential compared to embryonic stem cells but are more accepted for clinical use.
  3. Induced Pluripotent Stem Cells (iPSCs): These are adult cells that have been genetically reprogrammed to an embryonic stem cell-like state. They can differentiate into various cell types and have significant potential for personalized medicine.

Stem Cell Sources for Cervical Spinal Stenosis Treatment

  1. Bone Marrow-Derived Stem Cells: Harvested from the patient’s own bone marrow, these cells are rich in mesenchymal stem cells (MSCs) that can differentiate into cartilage, bone, and neural cells.
  2. Adipose-Derived Stem Cells: Obtained from fat tissue through liposuction, these MSCs are easy to harvest and can differentiate into various cell types.
  3. Peripheral Blood Stem Cells: Stem cells can be collected from peripheral blood using a process called apheresis. These cells can differentiate into different cell types, including neural cells.

How Stem Cell Therapy Works for Cervical Spinal Stenosis

Stem cell therapy aims to promote healing and regeneration in the cervical spine by introducing stem cells into the affected area. The therapy works in several ways:

Differentiation and Regeneration

Stem cells have the ability to differentiate into various cell types, including neural cells, cartilage, and bone. By introducing these cells into the cervical spine, the goal is to promote the regeneration of damaged tissues, including intervertebral discs and spinal ligaments.

Anti-Inflammatory Effects

Stem cells can secrete anti-inflammatory cytokines and growth factors that help reduce inflammation and modulate the immune response. This can alleviate pain and other symptoms associated with cervical spinal stenosis.

Neuroprotective Properties

Stem cells can provide support and protection to existing nerve cells, promoting neural repair and function. This can improve neurological symptoms and overall quality of life.

Benefits of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Stem cell therapy offers several potential benefits for patients with cervical spinal stenosis:

Non-Invasive or Minimally Invasive

Most stem cell therapies involve minimally invasive procedures, such as injections into the affected area. This reduces the risks and recovery time associated with surgery.

Reduced Inflammation and Pain

The anti-inflammatory and regenerative properties of stem cells can help alleviate pain and reduce inflammation in the cervical spine.

Potential for Tissue Regeneration

Stem cells can promote the regeneration of damaged tissues, including intervertebral discs and spinal ligaments, potentially leading to long-term improvement.

Neuroprotection and Neural Repair

Stem cells can provide support to existing nerve cells, promoting neural repair and improving neurological symptoms.

Personalized Treatment

Stem cell therapy can be personalized based on the patient’s specific condition and needs, including the choice of stem cell source and delivery method.

Considerations in Stem Cell Therapy

While stem cell therapy holds promise, there are challenges and considerations to address:

Safety and Efficacy

Ensuring the safety and efficacy of stem cell therapy is crucial. Potential risks include immune rejection, uncontrolled cell growth, and the possibility of forming tumors.

Standardization and Quality Control

There is a need for standardized protocols and quality control measures in stem cell therapy to ensure consistent and reliable results.

Prospects and Research Directions

Stem cell therapy for cervical spinal stenosis is an evolving field with promising research directions:

Advances in Stem Cell Sources and Delivery

  • Researchers are exploring new sources of stem cells, such as iPSCs, which offer potential for personalized therapy.
  • Innovations in delivery methods, such as biomaterial scaffolds and hydrogels, may improve stem cell transplantation outcomes.

Combination Therapies

Combining stem cell therapy with other treatments, such as gene therapy or growth factors, may enhance therapeutic effects and improve outcomes.

Clinical Trials and Research

Ongoing and future clinical trials will provide valuable data on the safety, efficacy, and long-term outcomes of stem cell therapy for cervical spinal stenosis.

Personalized Medicine

As research progresses, personalized medicine approaches may allow for tailored stem cell therapies based on individual patient profiles, improving outcomes and reducing risks.

Stem Cell Therapy in India

India is rapidly emerging as a hub for stem cell research and therapy. With its growing healthcare sector and skilled medical professionals, the country is well-positioned to make significant contributions to the field.

Research and Development

India boasts several research institutions and universities dedicated to advancing stem cell research. Collaborative efforts between academic institutions and industry players have resulted in progress in developing stem cell-based treatments for various conditions, including cervical spinal stenosis.

Regulatory Environment

The Indian government has established regulations to oversee the use of stem cell therapies, focusing on safety, efficacy, and ethical considerations. This regulatory framework aims to ensure that stem cell treatments are conducted responsibly and in the best interests of patients.

Clinical Applications

Indian medical professionals and researchers are actively involved in clinical trials and studies exploring the potential of stem cell therapy for cervical spinal stenosis. The country’s large population and diverse patient pool provide valuable data for evaluating the safety and efficacy of stem cell treatments.

New Hope for Good Outcomes

Stem cell therapy has significant potential in treating cervical spinal stenosis by promoting tissue regeneration, reducing inflammation, and providing neuroprotection. While there are challenges and considerations to address, ongoing research and advances in stem cell technology offer hope for improved treatments and outcomes. As clinical trials continue to explore the safety and efficacy of stem cell therapy, this innovative approach may become a viable option for patients with cervical spinal stenosis in the future.

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma

Unraveling the Success Rates of Stem Cell Transplants for Scleroderma

Cervical Spinal Stenosis

Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis

Diabetic Neuropathy

Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy

Stem cell transplant success rate for scleroderma
Unraveling the Success Rates of Stem Cell Transplants for Scleroderma
Cervical Spinal Stenosis
Potential of Stem Cell Therapy in Treating Cervical Spinal Stenosis
Diabetic Neuropathy
Stem Cell Therapy as a Promising Solution for Diabetic Neuropathy
Success Rates of Stem Cell Therapy for Hip Conditions
Success Rates of Stem Cell Therapy for Hip Conditions
Potential of Stem Cell Treatment in Managing Azoospermia
Potential of Stem Cell Treatment in Managing Azoospermia
Male fertility after autologous stem cell transplant
Male Fertility Restoration Post-Autologous Stem Cell Transplant
Unveiling the Role of Stem Cell Therapy in Addressing Low AMH
Unveiling the Role of Stem Cell Therapy in Addressing Low AMH
Revolutionizing Treatment: Stem Cell Therapy for Hip Osteoarthritis
Revolutionizing Treatment: Stem Cell Therapy for Hip Osteoarthritis
stem cell therapy for feet
Unlocking the Potential of Stem Cell Therapy for Feet
Science Behind PRP Injections for Erectile Dysfunction Treatment
Science Behind PRP Injections for Erectile Dysfunction Treatment

Stella, a 48-year-old patient from the Brazil, got stem cell treatment for ALS and continues to see progresses in her health state. Stella received regenerative treatment, which included inoculations via IV and lumbar puncture, physiotherapy, and occupational therapy. Following the treatment, this 48-year-old ALS patient reports that she saw more than a few improvements to her condition. Getting up on her own feet, Stella observes more power in her legs as well as in the joints. Also, she can now sit up with the shoulder and back straight. In her interview, Stella shared her feelings that she has made a correct decision coming here to go through stem cell treatment. She is also enormously enthusiastic to see even more improvements in the future.

Stella

Mr. Farooq Hamid journeyed all the way from UAE to Apollo Hospitals in India for undergoing open heart bypass surgery. While the bypass surgery was successful, Mr. Farooq wants to thank the considerate team of Viezec as it him helped a lot. Mr. Hamid wants to express his gratitude towards Viezec, “I categorically have no words to thank Viezec and its team. Now, I can retrace my steps to my country without any dread of the medical complications I could probably have had. The doctors have given me my life back at the Apollo Hospitals”.

A healthy Farooq was discharged from Apollo Hospitals after a prosperous open bypass surgery performed by the hospital’s chief cardiovascular surgeon. Mr. Hamid says that everyone has been categorically great here with him. He had gone for the private roué in UAE in the past, but he feels that the care and amenities in India are easily comparable with any country, including his own.

Mr. Farooq

Mrs. Shirley from Australia decided to undergo her radiotherapy treatment for her treatment of brain tumor in Delhi, India. Fir this, she is very thankful to the team of Viezec, as she chose to avail the medical tourism services via this company. She suffered from a benevolent brain tumor, called Meningioma, with only some symptoms. However, she had to wait for around 3 months for her MRI scan and post that, with the cooperation of Viezec’s team and the doctor’s diligence, her radiotherapeutic treatment started and lasted for around 2 months.

When she contacted the team of Viezec, the professional team revised her medical records and she was given an appointment right away. She had to plan a 2 week stay for the ambulatory radiotherapy in India. The modern technology radiotherapy treated her brain tumor in a gentle and painless way. She could go back to her everyday activities right after every treatment sitting. After the last sitting and a final consultation, she took her flight home, gratified and glad the she didn’t had to go through surgery, leave alone a lengthy retrieval and further bleeding hazards. She is very thankful to Viezec’s services.

Shirley

Stella, a 48-year-old patient from the Brazil, got stem cell treatment for ALS and continues to see progresses in her health state. Stella received regenerative treatment, which included inoculations via IV and lumbar puncture, physiotherapy, and occupational therapy. Following the treatment, this 48-year-old ALS patient reports that she saw more than a few improvements to her condition. Getting up on her own feet, Stella observes more power in her legs as well as in the joints. Also, she can now sit up with the shoulder and back straight. In her interview, Stella shared her feelings that she has made a correct decision coming here to go through stem cell treatment. She is also enormously enthusiastic to see even more improvements in the future.

Stella

Mr. Farooq Hamid journeyed all the way from UAE to Apollo Hospitals in India for undergoing open heart bypass surgery. While the bypass surgery was successful, Mr. Farooq wants to thank the considerate team of Viezec as it him helped a lot. Mr. Hamid wants to express his gratitude towards Viezec, “I categorically have no words to thank Viezec and its team. Now, I can retrace my steps to my country without any dread of the medical complications I could probably have had. The doctors have given me my life back at the Apollo Hospitals”.

A healthy Farooq was discharged from Apollo Hospitals after a prosperous open bypass surgery performed by the hospital’s chief cardiovascular surgeon. Mr. Hamid says that everyone has been categorically great here with him. He had gone for the private roué in UAE in the past, but he feels that the care and amenities in India are easily comparable with any country, including his own.

Mr. Farooq

Mrs. Shirley from Australia decided to undergo her radiotherapy treatment for her treatment of brain tumor in Delhi, India. Fir this, she is very thankful to the team of Viezec, as she chose to avail the medical tourism services via this company. She suffered from a benevolent brain tumor, called Meningioma, with only some symptoms. However, she had to wait for around 3 months for her MRI scan and post that, with the cooperation of Viezec’s team and the doctor’s diligence, her radiotherapeutic treatment started and lasted for around 2 months.

When she contacted the team of Viezec, the professional team revised her medical records and she was given an appointment right away. She had to plan a 2 week stay for the ambulatory radiotherapy in India. The modern technology radiotherapy treated her brain tumor in a gentle and painless way. She could go back to her everyday activities right after every treatment sitting. After the last sitting and a final consultation, she took her flight home, gratified and glad the she didn’t had to go through surgery, leave alone a lengthy retrieval and further bleeding hazards. She is very thankful to Viezec’s services.

Shirley

Stella, a 48-year-old patient from the Brazil, got stem cell treatment for ALS and continues to see progresses in her health state. Stella received regenerative treatment, which included inoculations via IV and lumbar puncture, physiotherapy, and occupational therapy. Following the treatment, this 48-year-old ALS patient reports that she saw more than a few improvements to her condition. Getting up on her own feet, Stella observes more power in her legs as well as in the joints. Also, she can now sit up with the shoulder and back straight. In her interview, Stella shared her feelings that she has made a correct decision coming here to go through stem cell treatment. She is also enormously enthusiastic to see even more improvements in the future.

Stella

Mr. Farooq Hamid journeyed all the way from UAE to Apollo Hospitals in India for undergoing open heart bypass surgery. While the bypass surgery was successful, Mr. Farooq wants to thank the considerate team of Viezec as it him helped a lot. Mr. Hamid wants to express his gratitude towards Viezec, “I categorically have no words to thank Viezec and its team. Now, I can retrace my steps to my country without any dread of the medical complications I could probably have had. The doctors have given me my life back at the Apollo Hospitals”.

A healthy Farooq was discharged from Apollo Hospitals after a prosperous open bypass surgery performed by the hospital’s chief cardiovascular surgeon. Mr. Hamid says that everyone has been categorically great here with him. He had gone for the private roué in UAE in the past, but he feels that the care and amenities in India are easily comparable with any country, including his own.

Mr. Farooq

Mrs. Shirley from Australia decided to undergo her radiotherapy treatment for her treatment of brain tumor in Delhi, India. Fir this, she is very thankful to the team of Viezec, as she chose to avail the medical tourism services via this company. She suffered from a benevolent brain tumor, called Meningioma, with only some symptoms. However, she had to wait for around 3 months for her MRI scan and post that, with the cooperation of Viezec’s team and the doctor’s diligence, her radiotherapeutic treatment started and lasted for around 2 months.

When she contacted the team of Viezec, the professional team revised her medical records and she was given an appointment right away. She had to plan a 2 week stay for the ambulatory radiotherapy in India. The modern technology radiotherapy treated her brain tumor in a gentle and painless way. She could go back to her everyday activities right after every treatment sitting. After the last sitting and a final consultation, she took her flight home, gratified and glad the she didn’t had to go through surgery, leave alone a lengthy retrieval and further bleeding hazards. She is very thankful to Viezec’s services.

Shirley

Stella, a 48-year-old patient from the Brazil, got stem cell treatment for ALS and continues to see progresses in her health state. Stella received regenerative treatment, which included inoculations via IV and lumbar puncture, physiotherapy, and occupational therapy. Following the treatment, this 48-year-old ALS patient reports that she saw more than a few improvements to her condition. Getting up on her own feet, Stella observes more power in her legs as well as in the joints. Also, she can now sit up with the shoulder and back straight. In her interview, Stella shared her feelings that she has made a correct decision coming here to go through stem cell treatment. She is also enormously enthusiastic to see even more improvements in the future.

Stella

Mr. Farooq Hamid journeyed all the way from UAE to Apollo Hospitals in India for undergoing open heart bypass surgery. While the bypass surgery was successful, Mr. Farooq wants to thank the considerate team of Viezec as it him helped a lot. Mr. Hamid wants to express his gratitude towards Viezec, “I categorically have no words to thank Viezec and its team. Now, I can retrace my steps to my country without any dread of the medical complications I could probably have had. The doctors have given me my life back at the Apollo Hospitals”.

A healthy Farooq was discharged from Apollo Hospitals after a prosperous open bypass surgery performed by the hospital’s chief cardiovascular surgeon. Mr. Hamid says that everyone has been categorically great here with him. He had gone for the private roué in UAE in the past, but he feels that the care and amenities in India are easily comparable with any country, including his own.

Mr. Farooq

Mrs. Shirley from Australia decided to undergo her radiotherapy treatment for her treatment of brain tumor in Delhi, India. Fir this, she is very thankful to the team of Viezec, as she chose to avail the medical tourism services via this company. She suffered from a benevolent brain tumor, called Meningioma, with only some symptoms. However, she had to wait for around 3 months for her MRI scan and post that, with the cooperation of Viezec’s team and the doctor’s diligence, her radiotherapeutic treatment started and lasted for around 2 months.

When she contacted the team of Viezec, the professional team revised her medical records and she was given an appointment right away. She had to plan a 2 week stay for the ambulatory radiotherapy in India. The modern technology radiotherapy treated her brain tumor in a gentle and painless way. She could go back to her everyday activities right after every treatment sitting. After the last sitting and a final consultation, she took her flight home, gratified and glad the she didn’t had to go through surgery, leave alone a lengthy retrieval and further bleeding hazards. She is very thankful to Viezec’s services.

Shirley

Stella, a 48-year-old patient from the Brazil, got stem cell treatment for ALS and continues to see progresses in her health state. Stella received regenerative treatment, which included inoculations via IV and lumbar puncture, physiotherapy, and occupational therapy. Following the treatment, this 48-year-old ALS patient reports that she saw more than a few improvements to her condition. Getting up on her own feet, Stella observes more power in her legs as well as in the joints. Also, she can now sit up with the shoulder and back straight. In her interview, Stella shared her feelings that she has made a correct decision coming here to go through stem cell treatment. She is also enormously enthusiastic to see even more improvements in the future.

Stella

Mr. Farooq Hamid journeyed all the way from UAE to Apollo Hospitals in India for undergoing open heart bypass surgery. While the bypass surgery was successful, Mr. Farooq wants to thank the considerate team of Viezec as it him helped a lot. Mr. Hamid wants to express his gratitude towards Viezec, “I categorically have no words to thank Viezec and its team. Now, I can retrace my steps to my country without any dread of the medical complications I could probably have had. The doctors have given me my life back at the Apollo Hospitals”.

A healthy Farooq was discharged from Apollo Hospitals after a prosperous open bypass surgery performed by the hospital’s chief cardiovascular surgeon. Mr. Hamid says that everyone has been categorically great here with him. He had gone for the private roué in UAE in the past, but he feels that the care and amenities in India are easily comparable with any country, including his own.

Mr. Farooq

Mrs. Shirley from Australia decided to undergo her radiotherapy treatment for her treatment of brain tumor in Delhi, India. Fir this, she is very thankful to the team of Viezec, as she chose to avail the medical tourism services via this company. She suffered from a benevolent brain tumor, called Meningioma, with only some symptoms. However, she had to wait for around 3 months for her MRI scan and post that, with the cooperation of Viezec’s team and the doctor’s diligence, her radiotherapeutic treatment started and lasted for around 2 months.

When she contacted the team of Viezec, the professional team revised her medical records and she was given an appointment right away. She had to plan a 2 week stay for the ambulatory radiotherapy in India. The modern technology radiotherapy treated her brain tumor in a gentle and painless way. She could go back to her everyday activities right after every treatment sitting. After the last sitting and a final consultation, she took her flight home, gratified and glad the she didn’t had to go through surgery, leave alone a lengthy retrieval and further bleeding hazards. She is very thankful to Viezec’s services.

Shirley

Stella, a 48-year-old patient from the Brazil, got stem cell treatment for ALS and continues to see progresses in her health state. Stella received regenerative treatment, which included inoculations via IV and lumbar puncture, physiotherapy, and occupational therapy. Following the treatment, this 48-year-old ALS patient reports that she saw more than a few improvements to her condition. Getting up on her own feet, Stella observes more power in her legs as well as in the joints. Also, she can now sit up with the shoulder and back straight. In her interview, Stella shared her feelings that she has made a correct decision coming here to go through stem cell treatment. She is also enormously enthusiastic to see even more improvements in the future.

Stella

Mr. Farooq Hamid journeyed all the way from UAE to Apollo Hospitals in India for undergoing open heart bypass surgery. While the bypass surgery was successful, Mr. Farooq wants to thank the considerate team of Viezec as it him helped a lot. Mr. Hamid wants to express his gratitude towards Viezec, “I categorically have no words to thank Viezec and its team. Now, I can retrace my steps to my country without any dread of the medical complications I could probably have had. The doctors have given me my life back at the Apollo Hospitals”.

A healthy Farooq was discharged from Apollo Hospitals after a prosperous open bypass surgery performed by the hospital’s chief cardiovascular surgeon. Mr. Hamid says that everyone has been categorically great here with him. He had gone for the private roué in UAE in the past, but he feels that the care and amenities in India are easily comparable with any country, including his own.

Mr. Farooq

Mrs. Shirley from Australia decided to undergo her radiotherapy treatment for her treatment of brain tumor in Delhi, India. Fir this, she is very thankful to the team of Viezec, as she chose to avail the medical tourism services via this company. She suffered from a benevolent brain tumor, called Meningioma, with only some symptoms. However, she had to wait for around 3 months for her MRI scan and post that, with the cooperation of Viezec’s team and the doctor’s diligence, her radiotherapeutic treatment started and lasted for around 2 months.

When she contacted the team of Viezec, the professional team revised her medical records and she was given an appointment right away. She had to plan a 2 week stay for the ambulatory radiotherapy in India. The modern technology radiotherapy treated her brain tumor in a gentle and painless way. She could go back to her everyday activities right after every treatment sitting. After the last sitting and a final consultation, she took her flight home, gratified and glad the she didn’t had to go through surgery, leave alone a lengthy retrieval and further bleeding hazards. She is very thankful to Viezec’s services.

Shirley

Menu